Clinical Trial 39751

Decatur, GA 30033


Study Summary:

This XanADu Phase II study in mild Alzheimer's Disease (AD) is to assess the safety, tolerability and efficacy of Xanamem™ in subjects with mild dementia due to Alzheimer's Disease.


Qualified Participants Must:

• Be 50 years of age or older
• Have mild dementia due to probable AD
• Have the availability of a study partner


Qualified Participants May Receive:

May be compensated for time and travel.


View Contact Phone Number


Research Site Profile

View Clinic Profile


Study is Available At:

NeuroStudies
2665 N. Decatur Rd. Suite 740
Decatur, GA 30033
View Clinic Location

 


If you would like to be contacted by the clinical trial representative and live within 100 miles of this clinic, please enter your contact information, then click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.